Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$3.28 USD
-0.05 (-1.36%)
Updated May 16, 2024 04:00 PM ET
After-Market: $3.27 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/02/2024
Time: -- |
6/2024 | $-0.23 | -4.24% |
Earnings Summary
For their last quarter, Ovid Therapeutics (OVID) reported earnings of -$0.17 per share, beating the Zacks Consensus Estimate of $-0.23 per share. This reflects a positive earnings surprise of 26.09%. Look out for OVID's next earnings release expected on August 02, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year decrease of 27.78%.
Earnings History
Price & Consensus
Zacks News for OVID
Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
OVID: What are Zacks experts saying now?
Zacks Private Portfolio Services